CEO of CEPHEID (CPHD, Financial) John L Bishop buys 5,000 shares of CPHD on 02/26/2009 at an average price of $7 a share.
Cepheid Inc. develops manufactures and markets microfluidic systems that integrate automate and accelerate biological testing. Their systems are miniaturized instruments that analyze complex biological samples in a disposable cartridge by combining molecular biology with microfluidic technology that processes small quantities of liquid typically using components fabricated with computer chip technology. These systems rapidly perform all of the steps required to analyze complex biological samples. CEPHEID has a market cap of $495.2 million; its shares were traded at around $6.78 with and P/S ratio of 2.92.
CPHD is in the portfolios of PRIMECAP Management.
Recent Trades of CEPHEID by CEO:
Recent Trades of CEPHEID by Directors and Officers:
Cepheid Inc. develops manufactures and markets microfluidic systems that integrate automate and accelerate biological testing. Their systems are miniaturized instruments that analyze complex biological samples in a disposable cartridge by combining molecular biology with microfluidic technology that processes small quantities of liquid typically using components fabricated with computer chip technology. These systems rapidly perform all of the steps required to analyze complex biological samples. CEPHEID has a market cap of $495.2 million; its shares were traded at around $6.78 with and P/S ratio of 2.92.
CPHD is in the portfolios of PRIMECAP Management.
Recent Trades of CEPHEID by CEO:
- Buy: CEO John L Bishop bought 5,000 shares of CPHD stock on 02/26/2009 at the average price of $7; the price of the stock has decreased by 3.14% since.
Recent Trades of CEPHEID by Directors and Officers:
- Sell: SVP, Research and Development Peter J Dailey sold 2,500 shares of CPHD stock on 01/26/2009 at the average price of $8.06; the price of the stock has decreased by 15.88% since.
- Sell: SVP, Research and Development Peter J Dailey sold 2,470 more shares of CPHD stock on 09/03/2008 at the average price of $18.39; the price of the stock has decreased by 63.13% since.
